phosphatidylcholines has been researched along with bithionol in 1 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (bithionol) | Trials (bithionol) | Recent Studies (post-2010) (bithionol) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 203 | 3 | 43 |
Protein | Taxonomy | phosphatidylcholines (IC50) | bithionol (IC50) |
---|---|---|---|
Mcl-1 | Homo sapiens (human) | 1.7844 | |
Estrogen receptor 1 | Homo sapiens (human) | 3.9409 | |
envelope glycoprotein | Human immunodeficiency virus 1 | 6.16 | |
estrogen receptor beta isoform 1 | Homo sapiens (human) | 8.1472 | |
Solute carrier family 22 member 2 | Homo sapiens (human) | 1.9 | |
Solute carrier family 22 member 1 | Homo sapiens (human) | 3.065 | |
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 8.78 | |
Solute carrier family 22 member 3 | Homo sapiens (human) | 5.5 | |
Epidermal growth factor receptor | Homo sapiens (human) | 0.614 | |
Transthyretin | Homo sapiens (human) | 2.7 | |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 2.147 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 2.255 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.235 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 1.67 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 1.67 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 1.67 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 1.67 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.824 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.829 | |
60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 2.8 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 1.67 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.829 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 1.226 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 4.392 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 5.515 | |
Substance-K receptor | Homo sapiens (human) | 4.659 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.235 | |
Thromboxane-A synthase | Homo sapiens (human) | 1.84 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 8.78 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.385 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 5.515 | |
Adenosine receptor A2a | Homo sapiens (human) | 1.167 | |
Mu-type opioid receptor | Homo sapiens (human) | 5.507 | |
D(3) dopamine receptor | Homo sapiens (human) | 4.218 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 6.789 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.829 | |
10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 2.8 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.181 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.318 | |
60 kDa chaperonin | Escherichia coli | 4.3 | |
10 kDa chaperonin | Escherichia coli | 4.3 | |
Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 6.6 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 5.2 | |
M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 42.88 | |
large T antigen | Betapolyomavirus macacae | 35.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ausubel, FM; Csatary, EE; Dekarske, MM; Faizi, HA; Fuchs, BB; Galle, N; Gao, H; Hari, TPA; Hendricks, GL; Huang, X; Kim, W; Lee, K; Mylonakis, E; Pan, W; Port, J; Ribeiro, NQ; Rosen, JL; Steele, AD; Tori, K; Vlahovska, PM; Wilt, IK; Wuest, WM; Zhu, W; Zou, G | 1 |
1 other study(ies) available for phosphatidylcholines and bithionol
Article | Year |
---|---|
A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant
Topics: Animals; Anti-Bacterial Agents; Bithionol; Cell Membrane; Cell Membrane Permeability; Cholesterol; Disease Models, Animal; Drug Repositioning; Drug Synergism; Gentamicins; Lipid Bilayers; Membrane Fluidity; Methicillin-Resistant Staphylococcus aureus; Molecular Dynamics Simulation; Phosphatidylcholines; Structure-Activity Relationship; Unilamellar Liposomes | 2019 |